Since last month, Irrfan Khan ha been out of all the limelight and buzz of Bollywood, he was also not active on social media. Yesterday, he took to twitter to tell us that he is suffering from a rare health condition.

Irrfan Khan has completed the shooting of another movie called Blackmail. Yesterday, when he revealed that he is suffering from a rare disease many people thought that this must be related to the promotion of his upcoming movie but later everyone realized how serious this issue is.

Irrfan Khan has left everyone very emotional and heart-broken and we couldn’t stop ourselves from shedding tears. Although, he hasn’t given any details about his disease nor has he disclosed anything yet but the in his tweet he mentioned, how his family and friends are supporting him in his tough times, he even requested everyone to not speculate anything until he tells them about his condition. Have a look at his tweet:

 

Although, the actor has requested everyone, especially the media people to not speculate about anything but some leading media houses took advantage of his condition and went ahead with fake reporting, stating that the actor is suffering from brain cancer.

Here have a look:

In these articles, they have written that the actor is suffering from Glioblastoma Multiforme grade IV. The report also states that he has been admitted to Kokilaben Ambani hospital in Mumbai.

But for your information, none of them is true. Komal Nahta, who is a trade analyst and a  close friend of Irrfan Khan has revealed something important that you really put these media houses to shame.

The tweet read:

“Although IrrfanKhan is unwell, all malicious news being spread about him and his condition since an hour or two are untrue. Likewise, all other horrendous news relating to his hospitalisation are fake. By God’s grace, Irrfan is in Delhi and that’s the only truth”

Well, this is the truth. We should not believe everything that we read online.

We wish that Irrfan Khan really gets well soon.

Share your thoughts in the comments below.